Relmada Therapeutics Set for Busy 2015 in Clinical Trials Developing Drugs for the Lucrative Pain Market
02. April 2015 08:30 ET
|
Relmada Therapeutics, Inc.
NEW YORK, NY--(Marketwired - April 02, 2015) - Relmada Therapeutics, Inc. (OTCQB: RLMD) has quite a busy 2015 ahead of it in the clinic. The pharmaceutical company has stepped up its work in a big...
Relmada Therapeutics Adds $15 Million in Capital to Expedite Development of Pain Treatment Drugs
29. Oktober 2014 09:00 ET
|
Relmada Therapeutics, Inc.
NEW YORK, NY--(Marketwired - October 29, 2014) - Relmada Therapeutics, Inc. (OTCQB: RLMD), a biopharmaceutical firm with four novel pain treatment drugs currently under development in its pipeline,...